THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM

被引：0
|
作者：
Sands, Bruce E.
Taub, Pam R.
Feagan, Brian G.
Armuzzi, Alessandro
Friedman, Gary S.
Moscariello, Michele
Lawendy, Nervin
Pedersen, Ronald D.
Chan, Gary
Nduaka, Chudy I.
Quirk, Daniel
Salese, Leonardo
Su, Chinyu
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1750
引用
收藏
页码：S380 / S380
页数：1
相关论文
共 50 条
  • [41] Tofacitinib in Ulcerative Colitis: Beyond Biologics?
    Anirvan, Prajna
    Giri, Suprabhat
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (03) : 515 - 515
  • [42] Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
    Deepak, Parakkal
    Alayo, Quazim A.
    Khatiwada, Aava
    Lin, Bixuan
    Fenster, Marc
    Dimopoulos, Christina
    Bader, Geoffrey
    Weisshof, Roni
    Jacobs, Michael
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    Christophi, George P.
    Patel, Anish
    Hirten, Robert P.
    Colombel, Jean-Frederic
    Rubin, David T.
    Ha, Christina
    Beniwal-Patel, Poonam
    Ungaro, Ryan C.
    Syal, Gaurav
    Pekow, Joel
    Cohen, Benjamin L.
    Yarur, Andres
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1592 - +
  • [43] Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis
    Ng, Alexander Clevewood
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (10): : 1774 - 1774
  • [44] TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: ANALYSIS OF INFECTION RATES FROM THE OCTAVE CLINICAL PROGRAM
    Winthrop, Kevin L.
    Loftus, Edward V.
    Baumgart, Daniel C.
    Reinisch, Walter
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Lawendy, Nervin
    Chan, Gary
    Pedersen, Ronald D.
    Friedman, Gary S.
    Su, Chinyu
    GASTROENTEROLOGY, 2018, 154 (06) : S388 - S388
  • [45] TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: ANALYSIS OF MALIGNANCY RATES FROM THE OCTAVE CLINICAL PROGRAM
    Lichtenstein, Gary R.
    Ciorba, Matthew A.
    Rogler, Gerhard
    Quirk, Daniel
    Nduaka, Chudy I.
    Pedersen, Ronald D.
    Lawendy, Nervin
    Chan, Gary
    Su, Chinyu
    Panes, Julian
    GASTROENTEROLOGY, 2018, 154 (06) : S385 - S386
  • [46] INCIDENCE OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL DEVELOPMENT PROGRAM: AN UPDATE AS OF MAY 2019
    Sandborn, William J.
    Panes, Julian
    Sands, Bruce E.
    Reinisch, Walter
    Modesto, Irene
    Su, Chinyu
    Steinwurz, Flavio
    Lawendy, Nervin
    Koram, Nana
    Kwok, Kenneth
    Jones, Thomas V.
    Thorpe, Andrew J.
    Quirk, Daniel
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S144 - S144
  • [47] Tofacitinib in ulcerative colitis - Small molecule but large effect
    Harindranath, Sidharth
    Singh, Ankita
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (02) : 371 - 372
  • [48] Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
    Chaparro, Maria
    Ceballos, Daniel
    Vicente, Raquel
    Gisbert, Javier P.
    CLINICAL DRUG INVESTIGATION, 2024, 44 (04) : 285 - 288
  • [49] Tofacitinib Adherence and Outcomes in Patients With Refractory Ulcerative Colitis
    Wiles, C. Alex
    Shah, Nisha
    Bell, Jacob
    Pabla, Baldeep S.
    Scoville, Elizabeth
    Dalal, Robin
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S411 - S411
  • [50] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
12345